NET Recovery wins FDA breakthrough tag for psychostimulant addiction device
NET Recovery’s neurostimulation device for stimulant use disorder has secured breakthrough device designation from the US Food and Drug Administration (FDA).…
23 Sep 2026
Teal Health raises $22m for at-home HPV cervical cancer screening test
Teal Health has raised $22m, with plans to apply the proceeds towards advancing access to its approved at-home human papillomavirus (HPV) screening kit ahead of a federal guideline update that…
23 Sep 2026
FDA clears Myrava’s patient-specific bolus device
Myrava, formerly known as Ricoh 3D for Healthcare, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its patient-specific, 3D-printed bolus device used in radiation therapy.…
23 Sep 2026
QC Healthcare and Sanguina collaborate for AI blood health tools
QC Healthcare has entered a collaboration with Sanguina to implement AI-based blood health technologies across its digital healthcare platforms in the US. The agreement will see Sanguina’s non-invasive screening tools,…
22 Sep 2026
Dialybrid raises $17m to advance Silkothane device
Italian medical device company Dialybrid has closed a €15m ($17m) Series A financing round to support the clinical development of its Silkothane arteriovenous graft for haemodialysis access. XGEN Venture led…
22 Sep 2026
FDA approves Cordis SELUTION SLR for coronary in-stent restenosis
The US Food and Drug Administration (FDA) has approved Cordis’ SELUTION SLR [sustained limus release] drug-eluting balloon (DEB) to treat coronary in-stent restenosis (ISR). This move brings a new device…
21 Sep 2026
Koning Health secures Australian TGA approval for breast CT system
Koning Health has received regulatory approval from Australia's Therapeutic Goods Administration (TGA) for its Koning Breast CT [computed tomography] System. Listed under ARTG No. 531059, the platform is included in…